PCN39 COST-UTILITY ANALYSIS IN A FRENCH SETTING OF ADJUVANT THERAPY WITH HERCEPTIN IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63469-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63469-9/fulltext
Title :
PCN39 COST-UTILITY ANALYSIS IN A FRENCH SETTING OF ADJUVANT THERAPY WITH HERCEPTIN IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63469-9&doi=10.1016/S1098-3015(10)63469-9
First page :
Section Title :
Open access? :
No
Section Order :
320